Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sentinel Oncology synthesizes novel Chk1 inhibitors

Dec. 5, 2011

Nerviano Medical Sciences presents preclinical findings on NMS-P948

Dec. 5, 2011

Researchers uncover mechanism of action of epigenetic modifier UVI-5008

Dec. 5, 2011

Celldex Therapeutics begins phase III trial of rindopepimut

Dec. 2, 2011

Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907

Dec. 2, 2011

Novel caspase-3 activators and apoptosis inducers reported in patent literature

Dec. 2, 2011

Novel PI3K and mTOR inhibitors patented by Spanish researchers

Dec. 2, 2011

Costimulatory fusion protein enhances activity of tumor vaccine in vivo

Dec. 2, 2011

First-in-human results presented on PRS-050 in patients with advanced solid malignancies

Dec. 2, 2011

Idera Pharmaceuticals regains global rights to IMO-2055

Dec. 1, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...